Last updated: January 18, 2021
Sponsor: King Abdullah International Medical Research Center
Overall Status: Active - Recruiting
Phase
2/3
Condition
Soft Tissue Infections
Treatment
N/AClinical Study ID
NCT04717037
RJ20/109/J
Ages 24-32 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Preterm infants born at one of the participated centers.
- Preterm Infants born at ≥24weeks gestation and ≤32weeks gestation
- Birth weight ≥ 500gm up to 2000 gm.
Exclusion
Exclusion Criteria:
- Outborn Infants.
- Preterm infants < 24wk or > 32 wk
- Preterm infants < 500 gm or > 2000gm
- Critically ill patients, e.g., Hemodynamic unstable, culture-confirmed neonatalsepsis, Hydrops fetalis, Life-threatening congenital anomalies.
- Congenital skin anomalies or infection
- Major surgical procedure
- Any patient whose parents refuse consent.
- Death within 48 hours of life.
Study Design
Total Participants: 300
Study Start date:
September 01, 2020
Estimated Completion Date:
August 01, 2022
Connect with a study center
King Abdulaziz Medical City
Jeddah, WR 21423
Saudi ArabiaActive - Recruiting
King Abdulaziz University Hospital
Jeddah,
Saudi ArabiaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.